GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon Pharma Indonesia PT (ISX:SCPI) » Definitions » Purchase Of Investment

Organon Pharma Indonesia PT (ISX:SCPI) Purchase Of Investment : Rp Mil (TTM As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Organon Pharma Indonesia PT Purchase Of Investment?

Organon Pharma Indonesia PT's purchase of investment for the three months ended in . 20 was Rp0.00 Mil. It means Organon Pharma Indonesia PT spent Rp0.00 Mil on purchasing investments.

Compared with last quarter (Rp0.00 Mil in . 20 ), Organon Pharma Indonesia PT spent the same money on purchasing investments in . 20 (Rp0.00 Mil).


Organon Pharma Indonesia PT Purchase Of Investment Historical Data

The historical data trend for Organon Pharma Indonesia PT's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Pharma Indonesia PT Purchase Of Investment Chart

Organon Pharma Indonesia PT Annual Data
Trend
Purchase Of Investment

Organon Pharma Indonesia PT Quarterly Data
Purchase Of Investment

Organon Pharma Indonesia PT Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.


Organon Pharma Indonesia PT Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Organon Pharma Indonesia PT's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Organon Pharma Indonesia PT (ISX:SCPI) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Jend Sudirman Kav 21, Sinarmas MSIG Tower, Floor 37 Unit 102 & 106, South Jakarta, IDN, 12920
Organon Pharma Indonesia PT engages in the development, manufacture, and distribution of pharmaceutical products. It operates through manufacturing and commercial segments. Manufacturing, which generates the majority of the revenue, is engaged in pharmaceutical manufacturing.

Organon Pharma Indonesia PT (ISX:SCPI) Headlines

No Headlines